Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care

Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim


Availability of the Q2 2023 Memorandum for modelling purposes


ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing


Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody


Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease